Our study demonstrates the presence of a 14-3-3ζ-Gli3-p27Kip1 axis that regulates adipocyte differentiation and suggest that targeting components of this axis may be a beneficial therapeutic approach for the treatment of obesity. Here, GLI3 is linked to obesity due to melanocortin 4 receptor deficiency.